The 36-month beta value for TNDM is also noteworthy at 1.32. There are mixed opinions on the stock, with 11 analysts rating it as a “buy,” 4 rating it as “overweight,” 7 rating it as “hold,” and 0 rating it as “sell.”
The public float for TNDM is 65.18M, and at present, short sellers hold a 11.01% of that float. The average trading volume of TNDM on January 31, 2025 was 1.29M shares.
TNDM) stock’s latest price update
Tandem Diabetes Care Inc (NASDAQ: TNDM)’s stock price has plunge by 1.79relation to previous closing price of 36.36. Nevertheless, the company has seen a 4.28% surge in its stock price over the last five trading sessions. zacks.com reported 2025-01-22 that TNDM’s shares rise as its expanding product portfolio gains market traction. However, the unfavorable macroeconomic scenario is concerning.
TNDM’s Market Performance
TNDM’s stock has risen by 4.28% in the past week, with a monthly rise of 0.35% and a quarterly rise of 13.01%. The volatility ratio for the week is 3.44% while the volatility levels for the last 30 days are 4.52% for Tandem Diabetes Care Inc The simple moving average for the last 20 days is 1.98% for TNDM stock, with a simple moving average of -5.80% for the last 200 days.
Analysts’ Opinion of TNDM
Many brokerage firms have already submitted their reports for TNDM stocks, with Morgan Stanley repeating the rating for TNDM by listing it as a “Overweight.” The predicted price for TNDM in the upcoming period, according to Morgan Stanley is $45 based on the research report published on December 02, 2024 of the previous year 2024.
Bernstein, on the other hand, stated in their research note that they expect to see TNDM reach a price target of $42. The rating they have provided for TNDM stocks is “Outperform” according to the report published on November 06th, 2024.
Goldman gave a rating of “Neutral” to TNDM, setting the target price at $46 in the report published on October 04th of the previous year.
TNDM Trading at 8.57% from the 50-Day Moving Average
After a stumble in the market that brought TNDM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -31.07% of loss for the given period.
Volatility was left at 4.52%, however, over the last 30 days, the volatility rate increased by 3.44%, as shares surge +0.38% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +29.45% upper at present.
During the last 5 trading sessions, TNDM rose by +4.28%, which changed the moving average for the period of 200-days by +10.48% in comparison to the 20-day moving average, which settled at $36.29. In addition, Tandem Diabetes Care Inc saw 2.75% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TNDM starting from BLICKENSTAFF KIM D, who sale 30,000 shares at the price of $31.38 back on Nov 21 ’24. After this action, BLICKENSTAFF KIM D now owns 165,190 shares of Tandem Diabetes Care Inc, valued at $941,400 using the latest closing price.
BLICKENSTAFF KIM D, the Director of Tandem Diabetes Care Inc, sale 10,000 shares at $30.00 during a trade that took place back on Nov 20 ’24, which means that BLICKENSTAFF KIM D is holding 195,190 shares at $300,000 based on the most recent closing price.
Stock Fundamentals for TNDM
Current profitability levels for the company are sitting at:
- -0.14 for the present operating margin
- 0.44 for the gross margin
The net margin for Tandem Diabetes Care Inc stands at -0.13. The total capital return value is set at -0.19. Equity return is now at value -45.96, with -13.36 for asset returns.
Based on Tandem Diabetes Care Inc (TNDM), the company’s capital structure generated 0.67 points at debt to capital in total, while cash flow to debt ratio is standing at 0.01. The debt to equity ratio resting at 2.0. The interest coverage ratio of the stock is -22.27.
Currently, EBITDA for the company is -194.66 million with net debt to EBITDA at -4.29. When we switch over and look at the enterprise to sales, we see a ratio of 2.93. The receivables turnover for the company is 9.08for trailing twelve months and the total asset turnover is 1.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.90.
Conclusion
In summary, Tandem Diabetes Care Inc (TNDM) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
